Table 3 Comparison of obstetric and neonatal outcomes between no-drugs, 1 or 2 drugs, and ≥ 3 psychotropic drugs groups.

From: The impact of the number of non-opioid psychotropic medications and their co-exposures during pregnancy on short-term outcomes in full-term neonates

 

Total

N = 358

No drug

N = 177

1 or 2 drugs

N = 139

 ≥ 3 drugs

N = 42

P-value

  

No drug

vs

1 or 2

1 or 2

vs

 ≥ 3

No drug

vs

 ≥ 3

Gestational ages at delivery

38 (37–41)

38 (37–41)

38 (37–41)

38 (37–40)

0.68

0.31

0.20

HDP

24 (6.7%)

10 (5.6%)

10 (7.2%)

4 (9.5%)

0.58

0.62

0.36

GDM

40 (11%)

20 (11%)

14 (10%)

6 (14%)

0.73

0.45

0.59

Epidural anesthesia

205 (37%)

95 (54%)

85 (61%)

25 (59%)

0.18

0.85

0.49

Cesarean section

105 (29%)

58 (33%)

31 (22%)

16 (38%)

0.14

0.14

0.74

Blood loss(g)

751 (145–3353)

784 (145–2616)

723 (250–3353)

779 (270–1994)

0.47

0.79

0.84

Birth Weight(g)

2963 (1850–4102)

2966 (1850–3738)

2952 (1950–3878)

2990 (2154–4102)

0.64

0.45

0.52

LFD

38 (11%)

17 (9.6%)

13 (9.4%)

8 (19%)

0.94

0.08

0.08

SGA

30 (8.4%)

18 (10%)

8 (5.8%)

4 (9.5%)

0.16

0.39

0.90

Apgar score at 1 min

8 (0–10)

8 (0–9)

8 (1–9)

8 (1–10)

0.04

0.50

0.056

Apgar score at 5 min

9 (1–10)

9 (3–10)

9 (1–10)

9 (4–10)

0.33

0.19

0.032

Umbilical artery pH

7.31 (6.93–7.48)

7.31 (6.95–7.48)

7.29 (6.93–7.48)

7.31 (7.15–7.39)

0.39

0.43

0.74

NICU admission

51 (14%)

25 (14%)

14 (10%)

12 (29%)

0.28

0.0028*

0.025

Respiratory ventilator treatment

15 (4.2%)

4 (2.3%)

6 (4.3%)

5 (12%)

0.30

0.07

0.0047*

NAS

9 (2.5%)

0 (0%)

4 (2.9%)

5 (12%)

0.023

0.0189

 < 0.0001*

Congenital Anomalies

18 (5.0.%)

10 (5.6%)

6 (4.3%)

2 (4.8%)

0.59

0.91

0.82

  1. median (range) or number (%).
  2. HDP: hypertensive disorders of pregnancy, GDM: gestational diabetes mellitus, LFD: large-for-date, SGA: small-for-gestational age, NICU: neonatal intensive care unit, NAS: neonatal abstinence syndrome.